Chemical Compound
N-[(3R,4R,5S,6R)-4-{[(2R,3R,4S,5R,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-{[(2S,3S,4R,5S,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}oxan-2-yl]oxy}-2-hydroxy-6-(hydroxymethyl)-5-{[(2S,3S,4R,5S,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}oxan-3-yl]acetamide
CAS Registry Number
80081-06-7
Primary record
N-[(3R,4R,5S,6R)-4-{[(2R,3R,4S,5R,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-{[(2S,3S,4R,5S,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}oxan-2-yl]oxy}-2-hydroxy-6-(hydroxymethyl)-5-{[(2S,3S,4R,5S,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}oxan-3-yl]acetamide
- 库存
- 8,091 克
- 纯度
- 99.8 %
- CAS
- 80081-06-7
化合物标识与属性
- CAS
- 80081-06-7
- PubChem CID
- 45480568
- SMILES
- C[C@H]1[C@H]([C@H]([C@@H]([C@@H](O1)O[C@@H]2[C@H](OC([C@@H]([C@H]2O[C@H]3[C@@H]([C@H]([C@H]([C@H](O3)CO)O)O)O[C@H]4[C@H]([C@@H]([C@@H]([C@@H](O4)C)O)O)O)NC(=O)C)O)CO)O)O)O
- Canonical SMILES
- CC(=O)N[C@H]1C(O)O[C@H](CO)[C@@H](O[C@@H]2O[C@@H](C)[C@@H](O)[C@@H](O)[C@@H]2O)[C@@H]1O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O[C@@H]1O[C@@H](C)[C@@H](O)[C@@H](O)[C@@H]1O
名称与同义词
- Lewis b antigen
- Leb glycan
- Lewis b
- LewisBtetrasaccharide
- Le(b)
- Lewis-b tetrasaccharide
- Lewis b Tetrasaccharide
- RefChem:604187
- GlyTouCan:G39211DH
- CHEBI:59440
- Epitope ID:131182
- SCHEMBL29400853
- G39211DH
- Fucalpha1-2Galbeta1-3[Fucalpha1-4]GlcNAc
- Fucalpha1-2Galbeta1-3(Fucalpha1-4)GlcNAc
- Fucalpha1-4(Fucalpha1-2Galbeta1-3)GlcNAc
- Fucalpha1-4[Fucalpha1-2Galbeta1-3]GlcNAc
- J3.720.694F
- alpha-L-Fucp-(1->2)-beta-D-Galp-(1->3)-[alpha-L-Fucp-(1->4)]-D-GlcNAc
- Q27126711
- 80081-06-7
- alpha-L-Fuc-(1->2)-beta-D-Gal-(1->3)-[alpha-L-Fuc-(1->4)]-D-GlcNAc
- 6-deoxy-alpha-L-galactopyranosyl-(1->4)-[6-deoxy-alpha-L-galactopyranosyl-(1->2)-beta-D-galactopyranosyl-(1->3)]-2-acetamido-2-deoxy-D-glucopyranose
- alpha-L-Fuc-(1->4)-[alpha-L-Fuc-(1->2)-beta-D-Gal-(1->3)]-D-GlcNAc
- alpha-L-fucopyranosyl-(1->4)-[alpha-L-fucopyranosyl-(1->2)-beta-D-galactopyranosyl-(1->3)]-2-acetamido-2-deoxy-D-glucopyranose
- alpha-L-fucosyl-(1->2)-beta-D-galactosyl-(1->3)-[alpha-L-fucosyl-(1->4)]-N-acetyl-D-glucosamine
- alpha-L-Fucp-(1->2)-beta-D-Galp-(1->3)-(alpha-L-Fucp-(1->4))-D-GlcNAc
- |A-Fuc(1 inverted exclamation marku2)-|A-Gal-(1 inverted exclamation marku3)-(|A-Fuc-[1 inverted exclamation marku4])-GlcNAc
- 4-O-(6-Deoxy-alpha-L-galactopyranosyl)-3-O-[2-O-(6-deoxy-alpha-L-galactopyranosyl)-beta-D-galactopyranosyl]-2-(acetylamino)-2-deoxy-D-glucopyranose
- alpha-L-fucopyranosyl-(1->4)-(alpha-L-fucopyranosyl-(1->2)-beta-D-galactopyranosyl-(1->3))-2-acetamido-2-deoxy-D-glucopyranose
- alpha-L-fucosyl-(1->4)-[alpha-L-fucosyl-(1->2)-beta-D-galactosyl-(1->3)]-N-acetyl-D-glucosamine
- N-[(3R,4R,5S,6R)-4-{[(2R,3R,4S,5R,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-{[(2S,3S,4R,5S,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}oxan-2-yl]oxy}-2-hydroxy-6-(hydroxymethyl)-5-{[(2S,3S,4R,5S,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}oxan-3-yl]acetamide